Get started
Author

Dara S. Missan

Observed names: D.S. Missan, Dara Missan
ORCID: 0000-0001-8094-5626
Observed ORCID: 0000-0001-8094-5626
OpenAlex ID: A5041966119
Integrin Control of Tumor Invasion
2012 · Dara S. Missan, Michael DiPersio · Critical Reviews in Eukaryotic Gene Expression · 49
Integrin α3β1 Signaling through MEK/ERK Determines Alternative Polyadenylation of the MMP-9 mRNA Transcript in Immortalized Mouse Keratinocytes
2015 · Dara S. Missan, Kara Mitchell, et al. · PLoS ONE · 25
PDF
Regulation of Fibulin-2 Gene Expression by Integrin α3β1 Contributes to the Invasive Phenotype of Transformed Keratinocytes
2014 · Dara S. Missan, Sridar V. Chittur, et al. · Journal of Investigative Dermatology · 24
PDF
Rapid infectious disease identification by next-generation DNA sequencing
2016 · Jeremy E. Ellis, Dara S. Missan, et al. · Journal of Microbiological Methods · 17
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers
2024 · Grace C. Russell, Yassin Hamzaoui, et al. · Cytotherapy · 15
Microbial community profiling of peripheral blood in myalgic encephalomyelitis/chronic fatigue syndrome
2018 · Jeremy E. Ellis, Dara S. Missan, et al. · Human Microbiome Journal · 9
PDF
Evidence for polymicrobial communities in explanted vascular filters and atheroma debris
2017 · Jeremy E. Ellis, Richard Heuser, et al. · Molecular and Cellular Probes · 9
Comparison of the prokaryotic and eukaryotic microbial communities in peripheral blood from amyotrophic lateral sclerosis, multiple sclerosis, and control populations
2019 · Jeremy E. Ellis, Dara S. Missan, et al. · Human Microbiome Journal · 7
PDF
Manufacturing Process Improvement for Scale up of an Autologous Adoptive T Cell Product
2024 · D.S. Missan, G.A. Reckard, et al. · Cytotherapy · 1
Microbial community profiling by next-generation DNA sequencing of adenocarcinoma of the prostate with evidence of ochratoxin A producing fungi
2022 · Stephen E. Fry, Mitchell Kaye, et al. · Experimental and Molecular Pathology · 1
PDF
Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma
2026 · Erin W. Meermeier, Dara S. Missan, et al. · Cancer Research Communications
Process Optimization: Standardizing Flow Cytometry Release Testing for Antigen-Activated T Cells with Preformulated Antibody Panel Technology
2025 · G.A. Reckard, D.S. Missan, et al. · Cytotherapy
Manual vs Automated Platelet Wash for T Cell Therapy Manufacturing Using An Automated Cell Processor.
2025 · D.S. Missan, G.A. Reckard, et al. · Cytotherapy
Abstract 6103: BCMA CAR engineering arms T cells with superior functions post ex vivo stimulation by MUC1 peptide-loaded autologous PBMCs
2025 · Kun Yun, R. Leo Sakemura, et al. · Cancer Research
VALIDATION OF A FLOW CYTOMETRY RELEASE ASSAY UTILIZING INSTITUTIONAL CLINICAL ASSAY FOR COMPARISON FOR TCRαß+/CD19+ DEPLETED HAPLOIDENTICAL HEMATOPOIETIC PROGENITOR CELL GRAFTS
2024 · G.A. Reckard, D.S. Missan, et al. · Cytotherapy
Process Development and Manufacturing: VALIDATION OF THE MANUFACTURING OF AUTOLOGOUS MUC-1 ACTIVATED T CELLS FOR A PHASE I DOSE ESCALATION TRIAL FOR PATIENTS WITH MULTIPLE MYELOMA
2022 · G.A. McCoy, C.A. Groen, et al. · Cytotherapy
Process Development and Manufacturing: CHARACTERIZING POLYFUNCTIONALITY OF MANUFACTURED T CELL PRODUCTS
2022 · D.S. Missan, C.A. Groen, et al. · Cytotherapy
Works count: 18
Citation count: 156
H-index: 7
I10-index: 5
Year
Topic
Type